Emil Novo Nordisk - Search News

Novo Nordisk Expands AI Partnership With Valo Health

GlobalData on MSN · 1d

Novo Nordisk and Valo expand cardiometabolic drug partnership

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic diseases, leveraging AI and extensive human datasets. The collaboration,

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial intelligence (AI) partnership aimed at discovering and developing up to 20 treatments for obesity,

U.S. News & World Report · 1d

Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).

Seeking Alpha on MSN · 1d

Novo Nordisk, Valo Health expand drug discovery deal

Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday an agreement to expand their existing collaboration to discover and develop new treatments targeting cardiometabolic diseases.

1don MSN

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Key Takeaways Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts ...

1d

Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals

Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results